Literature DB >> 24671917

Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.

Filip M Szymański1, Anna E Płatek, Grzegorz Karpiński, Edward Koźluk, Bartosz Puchalski, Krzysztof J Filipiak.   

Abstract

BACKGROUND: Obstructive sleep apnoea (OSA) and atrial fibrillation (AF) are two conditions highly prevalent in the general population. OSA is known to cause haemodynamic changes, oxidative stress, and endothelial damage, and therefore promote vascular and heart remodelling which results in AF triggering and exacerbation. Coexistence of OSA and AF influences the course of both diseases, and therefore should be taken into consideration in patient management strategy planning. AIM: To assess the prevalence of OSA in Polish AF patients, and to describe the clinical characteristics of patients with concomitant OSA and AF.
METHODS: We enrolled into the study 289 consecutive patients hospitalised in a tertiary, high-volume Cardiology Department with a primary diagnosis of AF. In addition to standard examination, all patients underwent an overnight sleep study to diagnose OSA, which was defined as apnoea-hypopnoea index (AHI) ≥ 5 per hour.
RESULTS: After applying exclusion criteria, the final analysis covered 266 patients (65.0% male, mean age 57.6 ± 10.1 years). OSA was present in 121 (45.49%) patients. Patients with OSA were older (59.6 ± 8.0 vs. 56.0 ± 11.4 years; p = 0.02), had higher body mass index (BMI; 30.9 ± 5.4 vs. 28.7 ± 4.4 kg/m²; p < 0.01) larger neck size (41.2 ± 3.8 vs. 39.3 ± 3.3 cm; p = 0.0001) and waist circumference (108.5 ± 13.1 vs. 107.7 ± 85.4 cm; p < 0.0001) than patients without OSA. There were no significant differences between the groups in terms of systolic and diastolic blood pressure or history of comorbidities (p > 0.05). OSA patients were less likely than non-OSA patients to have paroxysmal AF (62.0% vs. 75.9%; p = 0.02). Dividing newly diagnosed OSA patients according to the disease severity showed that mild OSA (AHI ≥ 5/h and < 15/h) was present in 27.82% of the study population, moderate OSA (AHI ≤ 15/h and ≥ 30/h) in 13.16% of patients, and severe OSA (> 30/h) in 4.51% of patients. No significant differences in terms of comorbidities and anthropometric features were seen between mild and moderate, between moderate and severe, and between mild and severe OSA.
CONCLUSIONS: OSA is highly prevalent in patients with AF in the Polish population, and affects approximately half of the patients. OSA patients are more likely to be older, have higher BMI, and greater waist and neck circumference. Persistent AF is the most common form of the arrhythmia in patients with OSA, while patients without OSA are more likely to have paroxysmal AF.

Entities:  

Mesh:

Year:  2014        PMID: 24671917     DOI: 10.5603/KP.a2014.0070

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  9 in total

Review 1.  The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.

Authors:  Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz
Journal:  Clin Res Cardiol       Date:  2018-04-12       Impact factor: 5.460

Review 2.  Management of Patients with Atrial Fibrillation: Focus on Treatment Options.

Authors:  Pawel Matusik; Jacek Lelakowski; Barbara Malecka; Jacek Bednarek; Remigiusz Noworolski
Journal:  J Atr Fibrillation       Date:  2016-10-31

Review 3.  Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.

Authors:  Brandon W Calenda; Valentin Fuster; Jonathan L Halperin; Christopher B Granger
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

4.  Obstructive Sleep Apnoea and Atrial Fibrillation.

Authors:  Ling Zhang; Yuemei Hou; Sunny S Po
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-03-15

5.  Heart failure and central sleep apnea in the era of implantable recorders.

Authors:  Irina Cabac-Pogorevici; Valeriu Revenco
Journal:  Anatol J Cardiol       Date:  2021-04       Impact factor: 1.596

6.  Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study.

Authors:  Filip M Szymanski; Krzysztof J Filipiak; Anna E Platek; Anna Hrynkiewicz-Szymanska; Marcin Kotkowski; Edward Kozluk; Marek Kiliszek; Janusz Sierdzinski; Grzegorz Opolski
Journal:  Sleep Breath       Date:  2015-01-08       Impact factor: 2.816

7.  Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea-validity of the 2MACE score.

Authors:  Anna E Platek; Filip M Szymanski; Krzysztof J Filipiak; Alicja Dudzik-Plocica; Bartosz Krzowski; Grzegorz Karpinski
Journal:  Sleep Breath       Date:  2017-02-02       Impact factor: 2.816

8.  Predictors of heart rhythm disturbances in hypertensive obese patients with obstructive sleep apnea.

Authors:  Lyudmila Sergeevna Korostovtseva; Nadezhda Edvinovna Zvartau; Oxana Petrovna Rotar; Yurii Vladimirovich Sviryaev; Aleksandra Olegovna Konradi
Journal:  J Geriatr Cardiol       Date:  2017-09       Impact factor: 3.327

9.  Role of Obstructive Sleep Apnea in Cognitive Impairment.

Authors:  Pamela Barletta; Alexandre R Abreu; Alberto R Ramos; Salim I Dib; Carlos Torre; Alejandro D Chediak
Journal:  Int J Head Neck Surg       Date:  2019 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.